| Literature DB >> 25197646 |
Ying Li1, Meng-Shan Tan2, Teng Jiang3, Lan Tan4.
Abstract
Alzheimer's disease (AD) is a familiar neurodegenerative disease in the elderly. In this paper, we will review current viewpoints of microglial activation, inflammatory regulatory systems, and their relationship with AD pathology and etiology. Microglia cells are macrophage and representative of the innate immune system in brain. AD brain is marked by obvious inflammatory features, in which microglial activation is the driving force. β-amyloid protein sedimentation activates microglia cells, which causes the inflammation in AD. Microglia cells have dual roles: they provoke the release of inflammatory factors and cytotoxins leading to neuronal injuries and death; on the other hand, they have the neuroprotective effects. Through this, we hope to illustrate that the anti-inflammatory defenses of neurons can be practiced in the future strategy for recuperating the balance between the levels of inflammatory mediators and immune regulators in AD.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25197646 PMCID: PMC4150406 DOI: 10.1155/2014/437483
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Figure 1A beta activates inflammatory mediators and the complement system on microglia and then generates free radicals and makes toxic effects on neurons; on the other hand glial cells phagocytize A beta chips.
Figure 2In physiological and pathological conditions, microglia transmit signal to astrocytes and astrocytes inhibit inflammation by dopamine receptors. In degenerative brain disease, microglia activation weakened, astrocytes' Drd2 signals descend too, resulting in excessive inflammation expression. DA: Dopamine.